Crane, Heidi M <br/><br/>
Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.  [electronic resource] 

 -  AIDS (London, England)  Jul 2007 
 - 1431-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0b013e3281fc9320  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Adult<br/>Age Factors<br/>Analysis of Variance<br/>Anti-HIV Agents--adverse effects<br/>Antiretroviral Therapy, Highly Active<br/>Body Weight<br/>Carbamates--adverse effects<br/>Creatinine--urine<br/>Didanosine--adverse effects<br/>Drug Interactions<br/>Female<br/>Furans<br/>Glomerular Filtration Rate--drug effects<br/>HIV Infections--drug therapy<br/>HIV-1<br/>Humans<br/>Kidney--drug effects<br/>Linear Models<br/>Male<br/>Middle Aged<br/>Organophosphonates--therapeutic use<br/>Sulfonamides--adverse effects<br/>Tenofovir<br/>Time Factors